Miyamoto Masahito, Kurita Noriaki, Suemitsu Kotaro, Murakami Masaaki
Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Am J Nephrol. 2017;45(4):356-364. doi: 10.1159/000466707. Epub 2017 Mar 17.
Most guidelines recommend the creation of arteriovenous fistula (AVF) in patients with chronic kidney disease (CKD) stage 4. However, an increasing number of studies suggest that early AVF creation leads to high rates of AVF failure and death before dialysis commencement. Only the Japanese guideline recommends AVF creation at CKD stage 5; however, no data are available regarding access-related outcomes at this stage.
This was a multicenter cohort study involving Japanese CKD stage 5 patients who underwent preemptive AVF creation from 2009 to 2013. The primary outcome was unnecessary AVF creation, defined as death before requiring dialysis or AVF failure before dialysis commencement. The secondary outcome was dialysis commencement. The associations with candidate predictors and the outcomes were examined.
A total of 303 patients were registered. Four cases of death before dialysis and 13 cases of AVF failure before dialysis commencement were observed. A total of 283 patients who advanced to dialysis were found to have functional AVFs. The cumulative incidences of unnecessary AVF creation and dialysis commencement at 1 year were 4.8 and 89.3%, respectively. Competing risk regression analyses showed that age ≥75 years (subhazard ratio [SHR] 3.12, 95% CI 1.20-8.09) and female gender (SHR 3.31, 95% CI 1.20-9.09) were associated with unnecessary AVF creation.
A low incidence of unnecessary AVF creation was revealed among Japanese patients who received AVF at CKD stage 5. These results may help clarify the natural history of unnecessary AVF creation for other countries reformatting their guidelines regarding late vascular access creation.
大多数指南建议在慢性肾脏病(CKD)4期患者中建立动静脉内瘘(AVF)。然而,越来越多的研究表明,早期建立AVF会导致AVF失败率和透析开始前死亡率升高。只有日本指南建议在CKD 5期建立AVF;然而,目前尚无该阶段与血管通路相关结局的数据。
这是一项多中心队列研究,纳入了2009年至2013年接受择期AVF建立的日本CKD 5期患者。主要结局是不必要的AVF建立,定义为在需要透析前死亡或透析开始前AVF失败。次要结局是透析开始。研究了候选预测因素与结局之间的关联。
共登记了303例患者。观察到4例透析前死亡和13例透析开始前AVF失败。共有283例进展至透析的患者被发现拥有功能良好的AVF。1年时不必要的AVF建立和透析开始的累积发生率分别为4.8%和89.3%。竞争风险回归分析显示,年龄≥75岁(亚风险比[SHR] 3.12,95%置信区间1.20 - 8.09)和女性(SHR 3.31,95%置信区间1.20 - 9.09)与不必要的AVF建立相关。
在CKD 5期接受AVF的日本患者中,不必要的AVF建立发生率较低。这些结果可能有助于阐明其他国家在重新制定关于晚期血管通路建立的指南时不必要的AVF建立的自然病程。